Free Trial
→ $30 stock to buy before Starlink goes public (WATCH NOW!) (From Paradigm Press) (Ad)tc pixel Free IINN Stock Alerts

Inspira Technologies OXY B.H.N. (IINN) Competitors

Inspira Technologies OXY B.H.N. logo
$0.48 0.00 (-0.38%)
Closing price 04:00 PM Eastern
Extended Trading
$0.48 +0.01 (+1.74%)
As of 06:44 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Compare

IINN vs. FEMY, ICCM, POAI, RVP, and IRIX

Should you be buying Inspira Technologies OXY B.H.N. stock or one of its competitors? The main competitors of Inspira Technologies OXY B.H.N. include Femasys (FEMY), IceCure Medical (ICCM), Predictive Oncology (POAI), Retractable Technologies (RVP), and IRIDEX (IRIX). These companies are all part of the "medical equipment" industry.

How does Inspira Technologies OXY B.H.N. compare to Femasys?

Femasys (NASDAQ:FEMY) and Inspira Technologies OXY B.H.N. (NASDAQ:IINN) are both small-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their earnings, valuation, institutional ownership, media sentiment, risk, profitability, dividends and analyst recommendations.

In the previous week, Inspira Technologies OXY B.H.N. had 2 more articles in the media than Femasys. MarketBeat recorded 3 mentions for Inspira Technologies OXY B.H.N. and 1 mentions for Femasys. Inspira Technologies OXY B.H.N.'s average media sentiment score of 0.50 beat Femasys' score of 0.00 indicating that Inspira Technologies OXY B.H.N. is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Femasys
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Inspira Technologies OXY B.H.N.
1 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Inspira Technologies OXY B.H.N. has lower revenue, but higher earnings than Femasys.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Femasys$2.29M10.54-$18.63M-$0.50N/A
Inspira Technologies OXY B.H.N.$290K58.97-$13.22MN/AN/A

Femasys has a beta of -2.26, indicating that its share price is 326% less volatile than the S&P 500. Comparatively, Inspira Technologies OXY B.H.N. has a beta of 2.16, indicating that its share price is 116% more volatile than the S&P 500.

65.3% of Femasys shares are owned by institutional investors. Comparatively, 12.7% of Inspira Technologies OXY B.H.N. shares are owned by institutional investors. 7.6% of Femasys shares are owned by insiders. Comparatively, 29.4% of Inspira Technologies OXY B.H.N. shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Inspira Technologies OXY B.H.N. has a net margin of 0.00% compared to Femasys' net margin of -812.74%. Inspira Technologies OXY B.H.N.'s return on equity of 0.00% beat Femasys' return on equity.

Company Net Margins Return on Equity Return on Assets
Femasys-812.74% -534.94% -116.29%
Inspira Technologies OXY B.H.N. N/A N/A N/A

Femasys currently has a consensus target price of $5.50, suggesting a potential upside of 1,276.72%. Inspira Technologies OXY B.H.N. has a consensus target price of $2.00, suggesting a potential upside of 320.43%. Given Femasys' stronger consensus rating and higher possible upside, analysts clearly believe Femasys is more favorable than Inspira Technologies OXY B.H.N..

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Femasys
1 Sell rating(s)
0 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
2.60
Inspira Technologies OXY B.H.N.
1 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.00

Summary

Inspira Technologies OXY B.H.N. beats Femasys on 9 of the 14 factors compared between the two stocks.

How does Inspira Technologies OXY B.H.N. compare to IceCure Medical?

Inspira Technologies OXY B.H.N. (NASDAQ:IINN) and IceCure Medical (NASDAQ:ICCM) are both small-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their dividends, risk, analyst recommendations, earnings, profitability, media sentiment, institutional ownership and valuation.

In the previous week, Inspira Technologies OXY B.H.N. had 2 more articles in the media than IceCure Medical. MarketBeat recorded 3 mentions for Inspira Technologies OXY B.H.N. and 1 mentions for IceCure Medical. Inspira Technologies OXY B.H.N.'s average media sentiment score of 0.50 beat IceCure Medical's score of 0.00 indicating that Inspira Technologies OXY B.H.N. is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Inspira Technologies OXY B.H.N.
1 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
IceCure Medical
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Inspira Technologies OXY B.H.N. has higher earnings, but lower revenue than IceCure Medical.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Inspira Technologies OXY B.H.N.$290K58.97-$13.22MN/AN/A
IceCure Medical$3.38M6.84-$15.06M-$0.24N/A

Inspira Technologies OXY B.H.N. has a beta of 2.16, suggesting that its stock price is 116% more volatile than the S&P 500. Comparatively, IceCure Medical has a beta of 0.47, suggesting that its stock price is 53% less volatile than the S&P 500.

12.7% of Inspira Technologies OXY B.H.N. shares are owned by institutional investors. Comparatively, 0.6% of IceCure Medical shares are owned by institutional investors. 29.4% of Inspira Technologies OXY B.H.N. shares are owned by company insiders. Comparatively, 2.4% of IceCure Medical shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Inspira Technologies OXY B.H.N. has a net margin of 0.00% compared to IceCure Medical's net margin of -445.61%. Inspira Technologies OXY B.H.N.'s return on equity of 0.00% beat IceCure Medical's return on equity.

Company Net Margins Return on Equity Return on Assets
Inspira Technologies OXY B.H.N.N/A N/A N/A
IceCure Medical -445.61%-221.04%-118.89%

Inspira Technologies OXY B.H.N. presently has a consensus price target of $2.00, indicating a potential upside of 320.43%. IceCure Medical has a consensus price target of $2.64, indicating a potential upside of 825.54%. Given IceCure Medical's stronger consensus rating and higher probable upside, analysts plainly believe IceCure Medical is more favorable than Inspira Technologies OXY B.H.N..

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Inspira Technologies OXY B.H.N.
1 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.00
IceCure Medical
1 Sell rating(s)
1 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.25

Summary

Inspira Technologies OXY B.H.N. beats IceCure Medical on 10 of the 14 factors compared between the two stocks.

How does Inspira Technologies OXY B.H.N. compare to Predictive Oncology?

Predictive Oncology (NASDAQ:POAI) and Inspira Technologies OXY B.H.N. (NASDAQ:IINN) are both small-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their dividends, analyst recommendations, valuation, profitability, earnings, media sentiment, institutional ownership and risk.

In the previous week, Inspira Technologies OXY B.H.N. had 2 more articles in the media than Predictive Oncology. MarketBeat recorded 3 mentions for Inspira Technologies OXY B.H.N. and 1 mentions for Predictive Oncology. Inspira Technologies OXY B.H.N.'s average media sentiment score of 0.50 beat Predictive Oncology's score of 0.00 indicating that Inspira Technologies OXY B.H.N. is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Predictive Oncology
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Inspira Technologies OXY B.H.N.
1 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Predictive Oncology has higher revenue and earnings than Inspira Technologies OXY B.H.N..

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Predictive Oncology$1.66M10.60-$12.66M-$13.50N/A
Inspira Technologies OXY B.H.N.$290K58.97-$13.22MN/AN/A

Inspira Technologies OXY B.H.N. has a consensus price target of $2.00, indicating a potential upside of 320.43%. Given Inspira Technologies OXY B.H.N.'s stronger consensus rating and higher possible upside, analysts plainly believe Inspira Technologies OXY B.H.N. is more favorable than Predictive Oncology.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Predictive Oncology
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00
Inspira Technologies OXY B.H.N.
1 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.00

Predictive Oncology has a beta of 1.35, suggesting that its share price is 35% more volatile than the S&P 500. Comparatively, Inspira Technologies OXY B.H.N. has a beta of 2.16, suggesting that its share price is 116% more volatile than the S&P 500.

9.0% of Predictive Oncology shares are owned by institutional investors. Comparatively, 12.7% of Inspira Technologies OXY B.H.N. shares are owned by institutional investors. 1.2% of Predictive Oncology shares are owned by company insiders. Comparatively, 29.4% of Inspira Technologies OXY B.H.N. shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Inspira Technologies OXY B.H.N. has a net margin of 0.00% compared to Predictive Oncology's net margin of -5,065.23%. Inspira Technologies OXY B.H.N.'s return on equity of 0.00% beat Predictive Oncology's return on equity.

Company Net Margins Return on Equity Return on Assets
Predictive Oncology-5,065.23% -732.73% -235.55%
Inspira Technologies OXY B.H.N. N/A N/A N/A

Summary

Inspira Technologies OXY B.H.N. beats Predictive Oncology on 12 of the 14 factors compared between the two stocks.

How does Inspira Technologies OXY B.H.N. compare to Retractable Technologies?

Retractable Technologies (NYSE:RVP) and Inspira Technologies OXY B.H.N. (NASDAQ:IINN) are both small-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their profitability, risk, earnings, valuation, analyst recommendations, media sentiment, dividends and institutional ownership.

Inspira Technologies OXY B.H.N. has a net margin of 0.00% compared to Retractable Technologies' net margin of -41.11%. Inspira Technologies OXY B.H.N.'s return on equity of 0.00% beat Retractable Technologies' return on equity.

Company Net Margins Return on Equity Return on Assets
Retractable Technologies-41.11% -17.15% -9.33%
Inspira Technologies OXY B.H.N. N/A N/A N/A

7.6% of Retractable Technologies shares are owned by institutional investors. Comparatively, 12.7% of Inspira Technologies OXY B.H.N. shares are owned by institutional investors. 59.5% of Retractable Technologies shares are owned by company insiders. Comparatively, 29.4% of Inspira Technologies OXY B.H.N. shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Retractable Technologies has a beta of 1.25, suggesting that its share price is 25% more volatile than the S&P 500. Comparatively, Inspira Technologies OXY B.H.N. has a beta of 2.16, suggesting that its share price is 116% more volatile than the S&P 500.

Inspira Technologies OXY B.H.N. has a consensus target price of $2.00, indicating a potential upside of 320.43%. Given Inspira Technologies OXY B.H.N.'s stronger consensus rating and higher probable upside, analysts clearly believe Inspira Technologies OXY B.H.N. is more favorable than Retractable Technologies.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Retractable Technologies
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
Inspira Technologies OXY B.H.N.
1 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.00

Retractable Technologies has higher revenue and earnings than Inspira Technologies OXY B.H.N..

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Retractable Technologies$38.27M0.57-$7.01M-$0.42N/A
Inspira Technologies OXY B.H.N.$290K58.97-$13.22MN/AN/A

In the previous week, Inspira Technologies OXY B.H.N. had 2 more articles in the media than Retractable Technologies. MarketBeat recorded 3 mentions for Inspira Technologies OXY B.H.N. and 1 mentions for Retractable Technologies. Inspira Technologies OXY B.H.N.'s average media sentiment score of 0.50 beat Retractable Technologies' score of 0.00 indicating that Inspira Technologies OXY B.H.N. is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Retractable Technologies
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Inspira Technologies OXY B.H.N.
1 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Summary

Inspira Technologies OXY B.H.N. beats Retractable Technologies on 11 of the 14 factors compared between the two stocks.

How does Inspira Technologies OXY B.H.N. compare to IRIDEX?

IRIDEX (NASDAQ:IRIX) and Inspira Technologies OXY B.H.N. (NASDAQ:IINN) are both small-cap medical equipment companies, but which is the better investment? We will contrast the two businesses based on the strength of their profitability, risk, earnings, valuation, analyst recommendations, media sentiment, dividends and institutional ownership.

Inspira Technologies OXY B.H.N. has a net margin of 0.00% compared to IRIDEX's net margin of -8.42%. Inspira Technologies OXY B.H.N.'s return on equity of 0.00% beat IRIDEX's return on equity.

Company Net Margins Return on Equity Return on Assets
IRIDEX-8.42% -1,204.74% -14.39%
Inspira Technologies OXY B.H.N. N/A N/A N/A

20.1% of IRIDEX shares are owned by institutional investors. Comparatively, 12.7% of Inspira Technologies OXY B.H.N. shares are owned by institutional investors. 8.6% of IRIDEX shares are owned by company insiders. Comparatively, 29.4% of Inspira Technologies OXY B.H.N. shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

IRIDEX has a beta of 0.64, suggesting that its share price is 36% less volatile than the S&P 500. Comparatively, Inspira Technologies OXY B.H.N. has a beta of 2.16, suggesting that its share price is 116% more volatile than the S&P 500.

IRIDEX presently has a consensus target price of $3.00, indicating a potential upside of 185.71%. Inspira Technologies OXY B.H.N. has a consensus target price of $2.00, indicating a potential upside of 320.43%. Given Inspira Technologies OXY B.H.N.'s higher probable upside, analysts clearly believe Inspira Technologies OXY B.H.N. is more favorable than IRIDEX.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
IRIDEX
1 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.00
Inspira Technologies OXY B.H.N.
1 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.00

IRIDEX has higher revenue and earnings than Inspira Technologies OXY B.H.N..

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
IRIDEX$52.67M0.35-$4.44M-$0.26N/A
Inspira Technologies OXY B.H.N.$290K58.97-$13.22MN/AN/A

In the previous week, Inspira Technologies OXY B.H.N. had 2 more articles in the media than IRIDEX. MarketBeat recorded 3 mentions for Inspira Technologies OXY B.H.N. and 1 mentions for IRIDEX. Inspira Technologies OXY B.H.N.'s average media sentiment score of 0.50 beat IRIDEX's score of 0.00 indicating that Inspira Technologies OXY B.H.N. is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
IRIDEX
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Inspira Technologies OXY B.H.N.
1 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Summary

Inspira Technologies OXY B.H.N. beats IRIDEX on 9 of the 12 factors compared between the two stocks.

Get Inspira Technologies OXY B.H.N. News Delivered to You Automatically

Sign up to receive the latest news and ratings for IINN and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding IINN and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

IINN vs. The Competition

Export
MetricInspira Technologies OXY B.H.N.MED INSTRUMENTS IndustryMedical SectorNASDAQ Exchange
Market Cap$17.10M$7.14B$6.25B$11.87B
Dividend YieldN/A1.75%2.73%5.21%
P/E RatioN/A29.6029.0428.47
Price / Sales58.9755.86476.6160.94
Price / CashN/A24.9127.6236.52
Price / Book7.937.189.676.67
Net Income-$13.22M$158.34M$3.55B$332.53M
7 Day Performance-0.88%2.64%1.70%2.01%
1 Month Performance-1.39%4.99%5.62%9.20%
1 Year Performance-21.76%-3.14%34.42%39.59%

Inspira Technologies OXY B.H.N. Competitors List

Export
CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
IINN
Inspira Technologies OXY B.H.N.
1.967 of 5 stars		$0.48
-0.4%		$2.00
+320.4%		N/A$17.10M$290KN/A20
FEMY
Femasys
1.8042 of 5 stars		$0.37
0.0%		$5.50
+1,374.9%		N/A$22.52M$2.29MN/A30
ICCM
IceCure Medical
2.1633 of 5 stars		$0.27
-1.3%		$2.64
+875.6%		N/A$21.93M$3.38MN/A60
POAI
Predictive Oncology
0.0388 of 5 stars		$5.93
-11.0%		N/AN/A$20.13M$1.66MN/A30
RVP
Retractable Technologies
N/A$0.62
-0.4%		N/AN/A$18.59M$38.27MN/A240

Related Companies and Tools

Related Companies
Top 10 Stock Comparisons

This page (NASDAQ:IINN) was last updated on 5/5/2026 by MarketBeat.com Staff.
From Our Partners
Iran's New Leader Just Said Something That Should Terrify Every American
Iran's Supreme Leader has declared the Strait of Hormuz closed as leverage against the U.S. - and with 40% of ...
American Alternative | Sponsoredtc pixel
Your book attached
Your Download Link (Expiring) If you still haven't downloaded the free Simple Options Trading For Beginners...
Profits Run | Sponsoredtc pixel
My feud with Zohran Mamdani
Emmy-winning analyst releases his next big story Whitney Tilson shocked the nation on 60 Minutes when he ac...
Stansberry Research | Sponsoredtc pixel
The $1.75T "Backdoor" ticker (NOT Starlink)
When the SpaceX IPO launches, most investors will already be too late. The real opportunity isn't the IPO itse...
Behind the Markets | Sponsoredtc pixel
Sell 99% of Your Stocks, Do THIS Instead…
Millionaire Trader Exposes: "The Single Stock Income Plan" With over 6,000 stocks on the market to choose ...
The Oxford Club | Sponsoredtc pixel
Trade this between 9:30 and 10:45 am EST
The first 75 minutes of the trading day may be the most overlooked window for consistent opportunities.If you ...
Base Camp Trading | Sponsoredtc pixel
Iran War Shock: What I Was Told In That Private Meeting
You’re Being LIED To About The Iran War Forget EVERYTHING you’ve heard about the Iran war. Especially th...
Banyan Hill Publishing | Sponsoredtc pixel
Elon Unveils AI Passive Income Stream for Millions of Americans
During Tesla's last earnings call, Elon Musk outlined a new AI-driven approach he says could generate $30,000-...
InvestorPlace | Sponsoredtc pixel